ViewRay, Inc. (Nasdaq: VRAY) announced the pricing of an underwritten public offering of 16,216,217 shares of common stock at a price to the public of $9.25 per share, for gross proceeds of $150 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by ViewRay.
ViewRay, Inc. (Nasdaq: VRAY) today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock. All of the shares of common stock to be sold in the offering will be offered by ViewRay.
A new kind of medical technology company—ViewRay® Inc. designs, manufactures and markets MRIdian, the world’s first MRI-Guided radiation therapy system to image and treat cancer patients simultaneously.
Please log in to access the ViewRay Customer Portal. To request access, please click here. Request will be reviewed within 2 business days.